Improving the Quality and Efficiency of Pathology Diagnosis and Expanding Reporting Services
First written in FY2016. 14 of 15 entries say "Restated". Latest entry: FY2020.
0 other companies' latest entry also says "Restated".
- FY2020RestatedAnnual report
「In the diagnostic analysis business, the company worked to further improve quality and operating efficiency and expand services leveraging its genetic analysis technology and extensive pathology diagnostic expertise, including by establishing a testing service structure using a companion diagnostic system.」
The company continues to improve quality and efficiency in the diagnostic analysis business and expand services, including those using a companion diagnostic system. - FY2020-Q3RestatedAnnual report
「In the diagnostic analysis business, the company worked to further improve quality and operating efficiency and expand services leveraging its genetic analysis technology and extensive pathology diagnostic expertise, including by establishing a testing service structure using a companion diagnostic system.」
The company continues to improve quality and efficiency in the diagnostic analysis business, establish a testing structure using a companion diagnostic system, and expand genetic analysis and pathology diagnostic services. - FY2020-Q2RestatedAnnual report
「In the diagnostic analysis business, the company worked to further improve quality and operating efficiency and expand services leveraging its genetic analysis technology and extensive pathology diagnostic expertise, including by establishing a testing service structure using a companion diagnostic system.」
The company continues to improve quality and efficiency in the diagnostic analysis business, establish a testing structure using a companion diagnostic system, and expand genetic analysis and pathology diagnostic services. - FY2019RestatedAnnual report
「The company will focus on further improving quality and operating efficiency and work to enhance profitability.」
The company reaffirms its policy of improving quality and efficiency and enhancing profitability in its pathology diagnostics and diagnostic analysis services. - FY2019-Q3RestatedAnnual report
「In the diagnostic analysis business, the company worked to further improve quality and operating efficiency and expand services leveraging its genetic analysis technology and extensive pathology diagnostic expertise. It sought to secure medical institutions adopting its comprehensive cancer clinical sequencing service and strengthened sales of DTC (direct-to-consumer) genetic testing services.」
The company continues to improve quality and efficiency, expand genetic analysis and pathology diagnostic services, secure medical institutions adopting its clinical sequencing service, and strengthen sales of DTC genetic testing. - FY2019-Q2RestatedAnnual report
「In the diagnostic analysis business, the company worked to further improve quality and operating efficiency and expand services leveraging its genetic analysis technology and extensive pathology diagnostic expertise. It sought to secure medical institutions adopting its comprehensive cancer clinical sequencing service and strengthened sales of DTC (direct-to-consumer) genetic testing services.」
The company continues to improve quality and efficiency, expand genetic analysis and pathology diagnostic services, secure medical institutions adopting its cancer clinical sequencing service, and strengthen sales of DTC genetic testing. - FY2019-Q1RestatedAnnual report
「In the diagnostic analysis business, the company worked to further improve quality and operating efficiency and expand services leveraging its genetic analysis technology and extensive pathology diagnostic expertise」
The company continues to improve quality and efficiency in the diagnostic analysis business and expand genetic analysis and pathology diagnostic services. - FY2018-Q3RestatedAnnual report
「In the pathology diagnostics business, the company worked to further improve quality and operating efficiency and expand services leveraging its extensive pathology diagnostic expertise.」
The company continues to improve the quality and efficiency of pathology diagnostics and expand services leveraging its technology. - FY2018-Q2RestatedAnnual report
「In the pathology diagnostics business, the company worked to further improve quality and operating efficiency and expand services leveraging its extensive pathology diagnostic expertise.」
The company continues to pursue improved quality and efficiency in pathology diagnostics and service expansion leveraging its technology. - FY2018-Q1RestatedAnnual report
「In the pathology diagnostics business, the company worked to further improve quality and operating efficiency and expand services leveraging its extensive pathology diagnostic expertise.」
The company continues to pursue improved quality and efficiency in pathology diagnostics and service expansion. - FY2017RestatedAnnual report
「In the pathology diagnostics business, the company will focus on further improving quality and operating efficiency to restore profitability. It will also strengthen sales and order intake for self-collected HPV testing and actively expand services leveraging its extensive pathology diagnostic expertise.」
The company continues to pursue improved quality and efficiency in pathology diagnostics, self-collected HPV testing, and service expansion. - FY2017-Q3RestatedAnnual report
「In the pathology diagnostics business, the company worked to further improve quality and operating efficiency and expand services leveraging its extensive pathology diagnostic expertise. From 1 April last year, it also began providing a web-based pathology reporting system to meet requests from clinical staff for reports compatible with in-hospital electronic medical records and faster diagnoses.」
The company reiterates its initiatives to improve the quality and efficiency of pathology diagnostics and expand services through its web-based pathology reporting system. - FY2017-Q2RestatedAnnual report
「In the pathology diagnostics business, the company worked to further improve quality and operating efficiency and expand services leveraging its extensive pathology diagnostic expertise. From 1 April this year, it also began providing a web-based pathology reporting system to meet requests from clinical staff for reports compatible with in-hospital electronic medical records and faster diagnoses.」
The company continues to cite improving quality and efficiency and expanding services through its web-based pathology reporting system. - FY2017-Q1RestatedAnnual report
「In the pathology diagnostics business, the company worked to further improve quality and operating efficiency and expand services leveraging its extensive pathology diagnostic expertise. From 1 April this year, it also began providing a web-based pathology reporting system to meet requests from clinical staff for reports compatible with in-hospital electronic medical records and faster diagnoses.」
The company continues to cite improving the quality and efficiency of pathology diagnostics and expanding services through its web-based reporting system. - FY2016First statedAnnual report
「To further improve profitability, the company will focus on improving quality and operating efficiency. From 1 April this year, it began providing a web-based pathology reporting system to meet requests from clinical staff for reports compatible with in-hospital electronic medical records and faster diagnoses.」
As a measure to improve the quality and efficiency of pathology diagnostics, the company launched a web-based reporting system compatible with in-hospital electronic medical records.